Skip to main content

Investor

By Emily Olsen | 02:37 pm | March 24, 2022
Also: Diabetes care company Podimetrics raised $45 million, and employer-focused hybrid startup Radish Health brought in $4 million in seed funding.
By Laura Lovett | 02:31 pm | March 23, 2022
The company plans to use the new funds to launch its Stim Assist and its Alife mobile app. 
By Laura Lovett | 11:25 am | March 23, 2022
The app includes an AI software algorithm, which was cleared in 2020. 
By Emily Olsen | 02:52 pm | March 22, 2022
Also: Telehealth startup Antidote Health and fertility tech company Alife Health both raise $22 million.
By Emily Olsen | 12:29 pm | March 22, 2022
The company announced a deal with Indegene to launch Regulora, its recently FDA-approved prescription digital therapeutic for treating abdominal pain associated with IBS.
By Emily Olsen | 02:41 pm | March 21, 2022
The device, which is not yet cleared by the FDA, alerts bystanders to a potential cardiac event nearby and guides them to the scene.
By Laura Lovett | 01:27 pm | March 21, 2022
The company plans to use the money to build out its care coordination staff as well as its sales and marketing teams. 
By Emily Olsen | 01:06 pm | March 21, 2022
As part of the agreement, SoftBank will research market opportunities for the digital therapeutic, and it can negotiate an exclusive commercialization deal in Japan.
By Tammy Lovell | 04:22 am | March 18, 2022
The firm scored €500M in equity, debt funding.
By Emily Olsen | 04:27 pm | March 16, 2022
Also: Papa moves into the employer market, and Lark Health is working on a heart health platform.